Swiss Institute for Applied Cancer Research[Corporate Author] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2001	1
2003	1
2004	1
2025	0

Page 1

Evidence-based management options for women at increased breast/ovarian cancer risk.

Pichert G, Bolliger B, Buser K, Pagani O; Swiss Institute for Applied Cancer Research Network for Cancer Predisposition Testing and Counseling. Pichert G, et al. Ann Oncol. 2003 Jan;14(1):9-19. doi: 10.1093/annonc/mdg030. Ann Oncol. 2003. PMID: 12488287 Free article. Review.

Capecitabine with weekly paclitaxel for advanced breast cancer: a phase I dose-finding trial.

Uhlmann C, Ballabeni P, Rijken N, Brauchli P, Mingrone W, Rauch D, Pestalozzi BC, Rochlitz C, Aebi S; Swiss Group for Clinical Cancer Research; Swiss Institute for Applied Cancer Research. Uhlmann C, et al. Oncology. 2004;67(2):117-22. doi: 10.1159/000080997. Oncology. 2004. PMID: 15539915 Clinical Trial.

Response shift in the perception of health for utility evaluation. an explorative investigation.

Bernhard J, Lowy A, Maibach R, Hürny C; Swiss Group for Clinical Cancer Research (SAKK) and the Swiss Institute for Applied Cancer Research (SIAK), Bern, Switzerland. Bernhard J, et al. Eur J Cancer. 2001 Sep;37(14):1729-35. doi: 10.1016/s0959-8049(01)00196-4. Eur J Cancer. 2001. PMID: 11549425 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year